This report contains a summary of the data compiled during the evaluation of the test compound. The report is organized to present the results in a concise and easily interpretable manner. The first part contains items I-VI. Item I-IV provide sponsor and compound identification information, type of assay, and the protocol reference number. All protocol references indicate a standard procedure described in the Litton Bionetics, Inc. 'Screening Progra for the Identificatfan of Potential Mutagens and Carcinogens.' Item V identifies the tables and/or figures containing the data used by the study director in interpreting the test results. The interpretation of the results and conclusions are in Item VI. The second part of the report, entitled Study Design describes the materials and procedures employed in conducting the assay. This part of the report also contains evaluation criteria used by the study director, and any appendices.